Quintás-Cardama A - Search Results

1

Prognostic impact of the MDM2SNP309 allele in leukemia and lymphoma.

Post SM, Pant V, Abbas H, Quintás-Cardama A. Post SM, et al. Oncotarget. 2010 Jul;1(3):168-174. doi: 10.18632/oncotarget.123. Oncotarget. 2010. PMID: 21301048 Free PMC article. Review.

2

The p53-Mdm2 feedback loop protects against DNA damage by inhibiting p53 activity but is dispensable for p53 stability, development, and longevity.

Pant V, Xiong S, Jackson JG, Post SM, Abbas HA, Quintás-Cardama A, Hamir AN, Lozano G. Pant V, et al. Genes Dev. 2013 Sep 1;27(17):1857-67. doi: 10.1101/gad.227249.113. Epub 2013 Aug 23. Genes Dev. 2013. PMID: 23973961 Free PMC article.

3

Tumorigenesis promotes Mdm4-S overexpression.

Pant V, Larsson CA, Aryal N, Xiong S, You MJ, Quintas-Cardama A, Lozano G. Pant V, et al. Oncotarget. 2017 Apr 18;8(16):25837-25847. doi: 10.18632/oncotarget.15552. Oncotarget. 2017. PMID: 28460439 Free PMC article.

4

A high-frequency regulatory polymorphism in the p53 pathway accelerates tumor development.

Post SM, Quintás-Cardama A, Pant V, Iwakuma T, Hamir A, Jackson JG, Maccio DR, Bond GL, Johnson DG, Levine AJ, Lozano G. Post SM, et al. Cancer Cell. 2010 Sep 14;18(3):220-30. doi: 10.1016/j.ccr.2010.07.010. Cancer Cell. 2010. PMID: 20832750 Free PMC article.

5

p53 pathway dysfunction is highly prevalent in acute myeloid leukemia independent of TP53 mutational status.

Quintás-Cardama A, Hu C, Qutub A, Qiu YH, Zhang X, Post SM, Zhang N, Coombes K, Kornblau SM. Quintás-Cardama A, et al. Leukemia. 2017 Jun;31(6):1296-1305. doi: 10.1038/leu.2016.350. Epub 2016 Nov 25. Leukemia. 2017. PMID: 27885271

6

p53-dependent senescence delays Emu-myc-induced B-cell lymphomagenesis.

Post SM, Quintás-Cardama A, Terzian T, Smith C, Eischen CM, Lozano G. Post SM, et al. Oncogene. 2010 Mar 4;29(9):1260-9. doi: 10.1038/onc.2009.423. Epub 2009 Nov 23. Oncogene. 2010. PMID: 19935700 Free PMC article.

7

p53-independent ibrutinib responses in an Eμ-TCL1 mouse model demonstrates efficacy in high-risk CLL.

Lee HJ, Gallardo M, Ma H, Zhang X, Larsson CA, Mejia A, Hornbaker MJ, Qi Y, Su X, Pageon LR, Quintas-Cardama A, Post SM. Lee HJ, et al. Blood Cancer J. 2016 Jun 10;6(6):e434. doi: 10.1038/bcj.2016.41. Blood Cancer J. 2016. PMID: 27284738 Free PMC article.

8

Reverse phase protein array profiling reveals distinct proteomic signatures associated with chronic myeloid leukemia progression and with chronic phase in the CD34-positive compartment.

Quintás-Cardama A, Qiu YH, Post SM, Zhang Y, Creighton CJ, Cortes J, Kornblau SM. Quintás-Cardama A, et al. Cancer. 2012 Nov 1;118(21):5283-92. doi: 10.1002/cncr.27568. Epub 2012 Apr 19. Cancer. 2012. PMID: 22517119 Free PMC article.

9

The p53 pathway in hematopoiesis: lessons from mouse models, implications for humans.

Pant V, Quintás-Cardama A, Lozano G. Pant V, et al. Blood. 2012 Dec 20;120(26):5118-27. doi: 10.1182/blood-2012-05-356014. Epub 2012 Sep 27. Blood. 2012. PMID: 23018641 Free PMC article. Review.

10

Loss of TRIM62 expression is an independent adverse prognostic factor in acute myeloid leukemia.

Quintás-Cardama A, Zhang N, Qiu YH, Post S, Creighton CJ, Cortes J, Coombes KR, Kornblau SM. Quintás-Cardama A, et al. Clin Lymphoma Myeloma Leuk. 2015 Feb;15(2):115-127.e15. doi: 10.1016/j.clml.2014.07.011. Epub 2014 Aug 12. Clin Lymphoma Myeloma Leuk. 2015. PMID: 25248926 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

209 results

Search Page

Filters